Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tamayo

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|March 12, 2014
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed diseaseLan V Pham, Muychi T Vang, Archito T Tamayo, et al.
Blood|February 22, 2007
Development of a murine model for blastoid variant mantle-cell lymphomaRichard J Ford, Long Shen, Yen Chiu Lin-Lee, et al.
Oncotarget|October 8, 2016
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphomaLan V Pham, Jerry L Bryant, Richard Mendez, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 8, 2011
Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in GermanyM Schunk, P Reitmeir, S Schipf, et al.
Leukemia|August 28, 2013
Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphomaM Axelrod, Z Ou, L K Brett, et al.
Journal of Diabetes and Its Complications|December 16, 2014
Health-related quality of life in women and men with type 2 diabetes: a comparison across treatment groupsM Schunk, P Reitmeir, S Schipf, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2012
The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studiesW Maier, R Holle, M Hunger, et al.
Oncotarget|February 9, 2018
Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphomaWei Liu, Juan Chen, Archito T Tamayo, et al.
Biochemical Pharmacology|June 13, 2012
The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphomaMi-Ae Lyu, Lan V Pham, Bokyung Sung, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2012
Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium)S Schipf, A Werner, T Tamayo, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|March 12, 2014
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed diseaseLan V Pham, Muychi T Vang, Archito T Tamayo, et al.
Blood|February 22, 2007
Development of a murine model for blastoid variant mantle-cell lymphomaRichard J Ford, Long Shen, Yen Chiu Lin-Lee, et al.
Oncotarget|October 8, 2016
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphomaLan V Pham, Jerry L Bryant, Richard Mendez, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 8, 2011
Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in GermanyM Schunk, P Reitmeir, S Schipf, et al.
Leukemia|August 28, 2013
Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphomaM Axelrod, Z Ou, L K Brett, et al.
Journal of Diabetes and Its Complications|December 16, 2014
Health-related quality of life in women and men with type 2 diabetes: a comparison across treatment groupsM Schunk, P Reitmeir, S Schipf, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2012
The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studiesW Maier, R Holle, M Hunger, et al.
Oncotarget|February 9, 2018
Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphomaWei Liu, Juan Chen, Archito T Tamayo, et al.
Biochemical Pharmacology|June 13, 2012
The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphomaMi-Ae Lyu, Lan V Pham, Bokyung Sung, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2012
Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium)S Schipf, A Werner, T Tamayo, et al.
Pageof 4